Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and Warfarin
Information source: University of Pennsylvania
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Prescribers' Drug Orders
Intervention: Trimethoprim/Sulfamethoxazole and Warfarin (Drug)
Phase: N/A
Status: Terminated
Sponsored by: University of Pennsylvania
Summary
To determine if a computerized stop order will reduce the number of concurrent
trimethoprim/sulfamethoxazole and warfarin orders accepted through the inpatient electronic
ordering system while a patient is hospitalized.
Clinical Details
Official title: Randomized Controlled Study of a Computer Stop Order Versus Routine Practice When Trimethoprim/Sulfamethoxazole is Ordered Concurrently With Warfarin
Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)
Primary outcome: Reduce concomitant orders for warfarin and tmp/smx
Secondary outcome: Determine if computerized stop order will increase risk for inadvertent cessation of warfarinDetermine if computerized stop order will increase risk of delay of treatment with tmp/sulfa when determined to be necessary for treatment
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
All resident physicians and nurse practitioners involved in inpatient care.
Exclusion Criteria:
None-
Locations and Contacts
Additional Information
Starting date: August 2006
Last updated: March 26, 2009
|
